The orthopaedic match is one of the most competitive among medical subspecialties. Many factors are taken into account in the ranking of potential candidates. Resources are limited to guide medical students through this process. Practicing orthopaedic surgeon mentors and resident advisors often are asked to provide counseling and advice to enhance the applicant’s portfolio with limited information. This paper reviews the existing quantifiable data to assist orthopaedic surgery residency applicants. A literature review of articles written in English, which were either Pubmed or non-Pubmed indexed, was performed. The authors completed the review to concisely delineate factors that are often associated with a successful matching into an orthopaedic residency. Orthopaedic surgery continues to increase in competitiveness for the medical student residency match. While there is no one specific factor associated with success in the match, studies demonstrate that institutions often look favorably on students who rotate at that particular institution; this also is reflected in clinical performance scores if those rotators become residents at that particular program. Multiple factors are considered when matching orthopaedic surgery residency applicants. The information presented in this paper can help form the groundwork for discussions between mentors and students to maximize their chances for a successful match.
aDept of Orthopaedic Surgery, University of Miami/Miller School of Medicine
bDept of Orthopaedic Surgery, New York University, Hospital for Joint Disease
cDept of Orthopaedic Surgery, Rothman Institute/Thomas Jefferson University
dDept of Orthopaedic Surgery, University of California-San Diego
eDept of Orthopaedic Surgery, Penn Orthopaedic Institute/Hospital of the University of Pennsylvania
Financial Disclosure: Dr. Egol is a consultant for Exactech, serves on the board of OTA, and has received a grant from Synthes. Dr. Parvizi serves on numerous society and publication boards. He is a consultant for Convatech, Tissuegene, Ceramtec, Medtronic, Ethicon, and Pain Reform. He has received grants from: NIH, OREG, Stryker, Zimmer, 3 M, Ceramtec, Depuy, Pfizer, and Medtronic. He has received royalties from Elsevier, Wolters Kluwer, Slack, Data Trace, Jaypee Publishing. He discloses other relationships with Hip Innovation Tech, CD Diagnostics, Corentec, For MD, Alpheon Joint Purification Systems. Dr. Schwartz has received payment for lectures from AO. Dr. Mehta is a consultant for Synthes and Smith and Nephew. He has received grants from DOD, NIH, and OTA. He has received payment for lectures from Bioventus, Smith and Nephew, and royalties from Elsevier and Wolters Kluwer. Dr. Aiyer has no disclosures. The authors report no conflicts of interest in regard to this work.
Correspondence to Amiethab Aiyer, MD, University of Miami/BPEI, 900 NW 17th Street, Ste 10A, Rm 10 C, Miami, FL 33136 Tel: +215-510-1722; fax: +305-326-6585; e-mail: email@example.com.